The story of Viagra, formerly marketed by copyright, presents a intricate case study for stakeholders considering the healthcare landscape . Although its early success and generation of countless in revenue , the exclusivity end has opened the floodgates for generic medications, substantially diminishing income potential . This shift raises doubts